18595-15-8

Usage

Uses

Used in Pharmaceutical Industry:
METHYL 3-AMINO-5-METHYLBENZOATE is used as a chemical intermediate for the synthesis of various drugs, contributing to the development of new medicinal compounds.
Used in Dyes and Pigments Production:
METHYL 3-AMINO-5-METHYLBENZOATE is used as a component in the production of dyes and pigments, adding to the color spectrum used in different industries.
Used in Topical Pain Relief Formulations:
METHYL 3-AMINO-5-METHYLBENZOATE is used as a mild anesthetic agent in topical formulations to provide pain relief, particularly for minor skin irritations and injuries.
Safety Considerations:
It is important to handle METHYL 3-AMINO-5-METHYLBENZOATE with care due to its potential harmful effects if ingested or inhaled, and its ability to cause skin and eye irritation. Proper safety measures should be taken during its use and disposal.

InChI:InChI=1/C9H11NO2/c1-6-3-7(9(11)12-2)5-8(10)4-6/h3-5H,10H2,1-2H3

Upstream product

• 58530-13-5 3-bromo-5-methyl-benzoic acid 

Relevant academic research and scientific papers

FUSED BICYCLIC COMPOUNDS AND USES THEREOF IN MEDICINE

Fused bicyclic compounds and uses thereof in medicine. In particular, provided are fused bicyclic compounds used as ASK1 active regulator and and use of the compounds in the manufacture of a drug for treating a disease regulated by ASK1. Further provided are a pharmaceutical composition and a method of treating a disease regulated by ASK1 comprising administering the compounds or pharmaceutical composition thereof.

PROTEIN KINASE INHIBITORS FOR PROMOTING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH

The invention relates to MKK4 (mitogen-activated protein kinase 4) and their use in promoting liver regeneration or reducing or preventing hepatocyte death. The MKK4 inhibitors selectively inhibit protein kinase MKK4 over protein kinases JNK and MKK7.

1, 3, 4-BENZOTRIAZEPIN-2-ONE SALTS AND THEIR USE AS CCK RECEPTOR LIGANDS

This invention relates to pharmaceutically acceptable salts of compounds of formula (I) wherein: W is N or N+-O-; R2 is an optionally substituted C1 to C18 hydrocarbyl group wherein up to three C atoms may optionally be replaced by N, O and/or S atoms. R3 is -(CR11R12)m-X-(CR13R14)p-R9; m is 0, 1, 2, 3 or 4; p is 0, 1 or 2; X is a bond, -CR15=CR16-, -C≡C-, C(O)NH, NHC(O), C(O)NMe, NMeC(O), C(O)O, NHC(O)NH, NHC(O)O, OC(O)NH, NH, O, CO, SO2, SO2NH, C(O)NHNH, R9 is H ; C1 to C6 alkyl ; or phenyl, naphthyl, pyridyl, benzimidazolyl, indazolyl, quinolinyl, isoquinolinyl, tetrahydroisoquinolinyl, indolinyl, isoindolinyl, indolyl, isoindolyl or 2-pyridonyl substituted with -L-Q. R4 is an optionally substituted C1 to C18 hydrocarbyl group wherein up to three C atoms may optionally be replaced by N, O and/or S atoms ; and Such salts are useful, for example, for the treatment of gastrin related disorders.